BRAF and cancer: The fraction of cancer cells harbouring BRAF mutations, frequently acquired in melanoma, was markedly increased in mesenchymal samples, suggesting that a clonal fixation of this event may be key for the establishment of a fully mesenchymal state, which is in line with the observed dominance of this phenotype in skin cancers (Figure S4c).